المؤلفون: Lilly J H Brada, Quintus Molenaar, Koop Bosscha, Ronald M. van Dam, Ignace H. J. T. de Hingh, Vincent E de Meijer, Frank J. Wessels, Sebastiaan Festen, Yung C Nio, Lisa G Magermans, Jan J. J. de Vries, Rutger C G Bruijnen, Marco B. Polee, Krijn P van Lienden, Mike S L Liem, Olivier R. Busch, Lois A. Daamen, Hjalmar C. van Santvoort, Marc G. Besselink, Casper H.J. van Eijck, Gijs A. Patijn, Martijn W J Stommel, Hanneke Wilmink, Bas Groot Koerkamp, M.S. Walma, Diba Latifi

المساهمون: Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Surgery, Radiology and Nuclear Medicine, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Oncology, MUMC+: MA Heelkunde (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Epidemiologie

المصدر: Annals of Surgery, 274(5), 729-735. LIPPINCOTT WILLIAMS & WILKINS
Annals of surgery, 274(5), 729-735. Lippincott Williams and Wilkins
Annals of Surgery, 274, 729-735
Annals of Surgery, 274(5), 729-735. Lippincott Williams & Wilkins
Annals of Surgery, 274, 5, pp. 729-735

مصطلحات موضوعية: Male, Oxaliplatin/therapeutic use, FOLFIRINOX, SURGERY, IMPACT, Leucovorin, urologic and male genital diseases, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], QUALITY-OF-LIFE, Antineoplastic Combined Chemotherapy Protocols, Medicine, Prospective Studies, resection, Prospective cohort study, Netherlands, BORDERLINE, Survival Rate/trends, OUTCOMES, Leucovorin/therapeutic use, Hazard ratio, Middle Aged, locally advanced pancreatic cancer, Oxaliplatin, Survival Rate, Pancreatectomy/methods, Response Evaluation Criteria in Solid Tumors, Cohort, Female, Fluorouracil, medicine.medical_specialty, Irinotecan/therapeutic use, Urology, Antineoplastic Agents, Netherlands/epidemiology, Pancreas/pathology, Irinotecan, Fluorouracil/therapeutic use, Pancreatectomy, SDG 3 - Good Health and Well-being, Humans, Pancreatic Neoplasms/diagnosis, Propensity Score, Pancreas, NEOADJUVANT THERAPY, Neoplasm Staging, business.industry, Proportional hazards model, Antineoplastic Agents/therapeutic use, ADENOCARCINOMA, Confidence interval, Pancreatic Neoplasms, Propensity score matching, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ef9fb25d1e317bffbe82956feddc65Test
https://research.rug.nl/en/publications/879dd244-9b84-48da-b3fe-2dc2b8df7b87Test

المؤلفون: I. Quintus Molenaar, Susan van Dieren, Mirjam A. G. Sprangers, Marjolein Y.V. Homs, Casper H.J. van Eijck, Marc G. Besselink, Ignace H. J. T. de Hingh, Johanna W. Wilmink, Lydia G. M. van der Geest, Geert-Jan Creemers, Gijs A. Patijn, Jan-Willem B de Groot, Tara M. Mackay, Lonneke V. van de Poll-Franse, Judith de Vos-Geelen, Bas Groot Koerkamp, Hanneke W. M. van Laarhoven, Evelien J M de Jong, Anouk E J Latenstein, Hjalmar C. van Santvoort

المساهمون: Medical and Clinical Psychology, Surgery, Medical Oncology, Medical Psychology, APH - Mental Health, APH - Personalized Medicine, CCA - Cancer Treatment and Quality of Life, APH - Methodology, Oncology, CCA -Cancer Center Amsterdam, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, APH - Aging & Later Life, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Journal of the National Comprehensive Cancer Network, 18(10), 1354-1363. Cold Spring Publishing LLC
Journal of the National Comprehensive Cancer Network, 18(10), 1354-+. Cold Spring Publishing LLC
Journal of the National Comprehensive Cancer Network, 18(10), 1354-1363. Harborside Press

مصطلحات موضوعية: medicine.medical_specialty, Multivariate analysis, RESECTION, IMPACT, Adenocarcinoma, 03 medical and health sciences, 0302 clinical medicine, Quality of life, SDG 3 - Good Health and Well-being, Internal medicine, Surveys and Questionnaires, medicine, Periampullary cancer, Humans, REPORTED OUTCOMES, Patient Reported Outcome Measures, Prospective Studies, Registries, HEAD, Netherlands, Proportional hazards model, business.industry, STATEMENT, Hazard ratio, QLQ-C30, people.cause_of_death, humanities, Cancer registry, Pancreatic Neoplasms, Survival Rate, TRIALS, Oncology, 030220 oncology & carcinogenesis, Cohort, Quality of Life, 030211 gastroenterology & hepatology, HEALTH, business, people, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1cecba50c06fdfca2aede68f3d2eefTest
https://doi.org/10.6004/jnccn.2020.7579Test

المؤلفون: C. Yung Nio, Nadia Haj Mohammad, Krijn P van Lienden, Stijn van Roessel, Ronald M. van Dam, Hanneke Wilmink, M.S. Walma, Gijs A. Patijn, Ignace H. J. T. de Hingh, Lilly J H Brada, Martijn W J Stommel, Sebastiaan Festen, Jan J. J. de Vries, Mike L S Liem, Rutger C G Bruijnen, I. Quintus Molenaar, Lois A. Daamen, Vincent E de Meijer, Marco B. Polee, Olivier R. Busch, Marc G. Besselink, Koop Bosscha, Frank J. Wessels, Hjalmar C. van Santvoort, Maartje Los

المساهمون: Surgery, MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Epidemiologie, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Oncology, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism

المصدر: Journal of Surgical Oncology, 124(4), 589-597. Wiley
Journal of Surgical Oncology, 124, 4, pp. 589-597
Journal of Surgical Oncology. Wiley
Journal of surgical oncology, 124(4), 589-597. Wiley-Liss Inc.
Journal of Surgical Oncology, 124, 589-597

مصطلحات موضوعية: Male, FOLFIRINOX, medicine.medical_treatment, Leucovorin, urologic and male genital diseases, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, PROGNOSTIC-FACTORS, Antineoplastic Combined Chemotherapy Protocols, Medicine, CRITERIA, Prospective Studies, Superior mesenteric artery, resection, Neoadjuvant therapy, OUTCOMES, General Medicine, Middle Aged, CHEMOTHERAPY, Prognosis, Combined Modality Therapy, locally advanced pancreatic cancer, Oxaliplatin, Survival Rate, Oncology, 030220 oncology & carcinogenesis, Female, 030211 gastroenterology & hepatology, Fluorouracil, Radiology, medicine.drug, RADIOTHERAPY, medicine.medical_specialty, Irinotecan, survival, 03 medical and health sciences, Pancreatectomy, medicine.artery, Humans, CARBOHYDRATE ANTIGEN 19-9, Superior mesenteric vein, NEOADJUVANT THERAPY, Aged, business.industry, ADENOCARCINOMA, Nomogram, medicine.disease, Comorbidity, Gemcitabine, Pancreatic Neoplasms, Radiation therapy, Nomograms, GEMCITABINE, Surgery, business, COMORBIDITY, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55dff941118cd23668c375e63c76de0Test
https://cris.maastrichtuniversity.nl/en/publications/3029586f-c0e0-4bba-8664-98c07f1095acTest

المؤلفون: Cees H. Dejong, Arthur K.E. Elfrink, Thomas M. van Gulik, Hendrik A. Marsman, Koert F.D. Kuhlmann, Hans Torrenga, Koop Bosscha, Rutger-Jan Swijnenburg, Wouter W. te Riele, Eric J. Th. Belt, Dirk J. Grünhagen, Marc G. Besselink, Michel W.J.M. Wouters, Arjen M. Rijken, Carlijn I. Buis, N. Tjarda van Heek, Wouter K. G. Leclercq, Peter B. van den Boezem, Marcel den Dulk, Niels F.M. Kok, Maarten Vermaas, Mike S L Liem, Jeroen Hagendoorn, Joost M. Klaase, S. J. Oosterling, I. Quintus Molenaar, Cornelis Verhoef, J. Sven D. Mieog, Hasan H. Eker, Marieke T. de Boer, Gijs A. Patijn, Daan J. Lips, Esther C. J. Consten, Frederik H.J. Hoogwater, Erik W. van Zwet

المساهمون: ​Robotics and image-guided minimally-invasive surgery (ROBOTICS), Value, Affordability and Sustainability (VALUE), Groningen Institute for Organ Transplantation (GIOT), AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Surgery, CCA - Cancer biology and immunology, CCA - Cancer Treatment and Quality of Life, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9)

المصدر: European Journal of Surgical Oncology, 47(3), 649-659. ELSEVIER SCI LTD
European journal of surgical oncology, 47(3), 649-659. W.B. Saunders Ltd
European Journal of Surgical Oncology, 47, 649-659
European Journal of Surgical Oncology, 47, 3, pp. 649-659
EJSO-European Journal of Surgical Oncology, 47(3), 649-659. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 47(3), 649-659. W.B. Saunders

مصطلحات موضوعية: Liver Cirrhosis, Male, medicine.medical_specialty, Quality Assurance, Health Care, Demographics, Population, Adenocarcinoma, 030230 surgery, Logistic regression, Resection, Tertiary Care Centers, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Case mix index, All institutes and research themes of the Radboud University Medical Center, Internal medicine, Hepatectomy, Humans, Medicine, In patient, University medical, Mortality, education, Disease burden, Aged, Netherlands, Retrospective Studies, Aged, 80 and over, education.field_of_study, business.industry, Liver Neoplasms, Metastasectomy, Reproducibility of Results, General Medicine, Middle Aged, Hospitals, Fatty Liver, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Oncology, 030220 oncology & carcinogenesis, Female, Risk Adjustment, Surgery, Colorectal Neoplasms, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2085a13c43eeeccf6fa5f0294ae8b1c5Test
https://research.rug.nl/en/publications/95e23cde-9228-4ea6-9e3c-427d69818c5bTest

المؤلفون: Christiaan van der Leij, Krijn P. van Lienden, Jan J. J. de Vries, Nomdo S Renken, F. Daams, Ronald M. van Dam, C. Yung Nio, M. Liem, Thomas L. Bollen, Geert-Jan Creemers, Steffi J Rombouts, Judith de Vos-Geelen, Gijs A. Patijn, Maartje Los, Sebastiaan Festen, I. Quintus Molenaar, J. Nederend, Derk Jan A. de Groot, Rutger C G Bruijnen, Jan Willem B. de Groot, Joost G Blomjous, Leonie J. M. Mekenkamp, John J. Hermans, Nadia Haj Mohammad, Ignace H. J. T. de Hingh, Susana I S Patuleia, Johanna W. Wilmink, Thijs J Schouten, Maaike E Verweij, Lilly J H Brada, Hjalmar C. van Santvoort, Emile D. Kerver, Vincent E de Meijer, J.F.M. Pruijt, Annelie Vulink, Koop Bosscha, Frank J. Wessels, Maarten S. van Leeuwen, Marc G. Besselink, Marco B. Polee, Olivier R. Busch, Martijn R. Meijerink, M.S. Walma, Martijn W J Stommel

المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer biology and immunology, Ophthalmology, Internal medicine, VU University medical center, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and Nuclear Medicine, Oncology, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: European Journal of Surgical Oncology, 47(3), 699-707. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 47(3), 699-707. W.B. Saunders Ltd
for the Dutch Pancreatic Cancer Group 2021, ' Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer : A multicenter prospective cohort ', European Journal of Surgical Oncology, vol. 47, no. 3, pp. 699-707 . https://doi.org/10.1016/j.ejso.2020.11.137Test
European Journal of Surgical Oncology, 47, 699-707
European journal of surgical oncology, 47(3), 699-707. W.B. Saunders Ltd
European Journal of Surgical Oncology, 47, 3, pp. 699-707

مصطلحات موضوعية: Male, Antimetabolites, Antineoplastic, medicine.medical_specialty, Paclitaxel, FOLFIRINOX, medicine.medical_treatment, Locally advanced pancreatic cancer, Leucovorin, Adenocarcinoma, Irinotecan, Deoxycytidine, Cohort Studies, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], All institutes and research themes of the Radboud University Medical Center, Pancreatectomy, Albumins, Internal medicine, Pancreatic cancer, treatment strategies, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective Studies, Prospective cohort study, Response Evaluation Criteria in Solid Tumors, Aged, Chemotherapy, business.industry, General Medicine, Middle Aged, medicine.disease, Gemcitabine, Neoadjuvant Therapy, Oxaliplatin, Pancreatic Neoplasms, Survival Rate, Oncology, Cohort, Treatment strategy, Female, Surgery, Fluorouracil, business, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8a66a9183508390e581990d356d615Test
https://doi.org/10.1016/j.ejso.2020.11.137Test

المؤلفون: R.M. van Dam, I. H. J. T. de Hingh, V. E. de Meijer, Leonie J. M. Mekenkamp, Johanna W. Wilmink, Derk Jan A. de Groot, Martijn R. Meijerink, N. Haj Mohammad, J.F.M. Pruijt, Koop Bosscha, Gijs A. Patijn, M. Los, Lilly J H Brada, H.C. van Santvoort, G.J.M. Creemers, Marco B. Polee, Sebastiaan Festen, Geert A. Cirkel, J. de Vos-Geelen, Emile D. Kerver, I.Q. Molenaar, M.G. Besselink, M. Liem, J. A. Ropela, M.S. Walma, J.W.B. de Groot, Martijn W J Stommel

المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Epidemiologie, Graduate School, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer Treatment and quality of life, Internal medicine, VU University medical center, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: for the Dutch Pancreatic Cancer Group 2021, ' The treatment and survival of elderly patients with locally advanced pancreatic cancer : A post-hoc analysis of a multicenter registry ', Pancreatology, vol. 21, no. 1, pp. 163-169 . https://doi.org/10.1016/j.pan.2020.11.012Test
Pancreatology, 21, 163-169
Pancreatology, 21(1), 163-169. Elsevier
Pancreatology, 21, 1, pp. 163-169
Pancreatology, 21(1), 163-169. S. Karger AG
Pancreatology, 21(1), 163-169. ELSEVIER SCIENCE BV

مصطلحات موضوعية: Male, FOLFIRINOX, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Locally advanced pancreatic cancer, Kaplan-Meier Estimate, urologic and male genital diseases, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Elderly, DISPARITIES, Registries, NAB-PACLITAXEL, Aged, 80 and over, OUTCOMES, Incidence (epidemiology), Age Factors, Gastroenterology, Chemoradiotherapy, Induction Chemotherapy, Middle Aged, CHEMOTHERAPY, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, 030211 gastroenterology & hepatology, Best supportive care, medicine.drug, Adult, medicine.medical_specialty, Young Adult, 03 medical and health sciences, AGE, Drug Therapy, Internal medicine, Pancreatic cancer, Post-hoc analysis, medicine, Humans, Aged, Chemotherapy, Hepatology, OLDER PATIENTS, business.industry, ADENOCARCINOMA, medicine.disease, Survival Analysis, Comorbidity, Gemcitabine, Pancreatic Neoplasms, GEMCITABINE, business, COMORBIDITY

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5414ed7d7980dab4a07cdbd070c10f3dTest
https://research.vumc.nl/en/publications/01ec0bf4-0c27-4e80-99e6-7fc4c055e18fTest

المؤلفون: Mathieu D'Hondt, Sebastiaan Festen, Rutger C G Bruijnen, O.M. van Delden, E. M. van der Waal, I.H.J.T. de Hingh, J. A. Ropela, J. de Vos-Geelen, Johanna W. Wilmink, Chung Y. Nio, R.M. van Dam, Derk Jan A. de Groot, Geert Roeyen, J.W.B. de Groot, K.P. van Lienden, N. Haj Mohammad, S. J. Rombouts, O.R.C. Busch, Lilly J H Brada, G.J.M. Creemers, M. Liem, Gijs A. Patijn, J. de Vries, F. Daams, I.Q. Molenaar, V. E. de Meijer, M. S. van Leeuwen, Maartje Los, Leonie J. M. Mekenkamp, M.S. Walma, I. Oulad Abdennabi, P. Ghorbani, Martijn W J Stommel, H.C. van Santvoort, Elizabeth Pando, Emile D. Kerver, I. H. M. Borel Rinkes, J.F.M. Pruijt, R. van Hillegersberg, Koop Bosscha, Frank J. Wessels, Martijn R. Meijerink, Marc G. Besselink, Marco B. Polee

المساهمون: Dutch Pancreatic Cancer Group, Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, Internal medicine, MUMC+: MA Heelkunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Institut Català de la Salut, [Walma MS, Rombouts SJ, Brada LJH] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Departments of Surgery, Radiology and Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. [Borel Rinkes IH, Bruijnen RC] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. [Bosscha K] Departments of Surgery and Medical Oncology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands. [Pando E] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, CCA - Cancer Treatment and Quality of Life, Radiology and Nuclear Medicine, Amsterdam Cardiovascular Sciences, Cancer Center Amsterdam, Laboratory for General Clinical Chemistry, Oncology

المصدر: Trials, 22, 1
Trials
Trials, 22
Trials, 22(1):313. BioMed Central
Dutch Pancreatic Cancer Group 2021, ' Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial ', Trials, vol. 22, no. 1, 313 . https://doi.org/10.1186/s13063-021-05248-yTest
Trials, 22(1):313. BioMed Central Ltd
TRIALS, 22(1):313, 1-12. BMC
Scientia
Trials, Vol 22, Iss 1, Pp 1-12 (2021)

مصطلحات موضوعية: Oncology, Medicine (General), Radiofrequency ablation, FOLFIRINOX, SURGERY, medicine.medical_treatment, Locally advanced pancreatic cancer, INTERNATIONAL STUDY-GROUP, Medicine (miscellaneous), 030230 surgery, law.invention, Study Protocol, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Quimioteràpia, Clinical endpoint, Multicenter Studies as Topic, Pharmacology (medical), Overall survival, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], Otros calificadores::/terapia [Otros calificadores], Netherlands, Randomized Controlled Trials as Topic, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Extirpació (Cirurgia), TUMORS, Progression-Free Survival, 030220 oncology & carcinogenesis, SURVIVAL, terapéutica::tratamiento de radiofrecuencia::ablación por radiofrecuencia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], medicine.drug, medicine.medical_specialty, CLINICAL-OUTCOMES, Therapeutics::Radiofrequency Therapy::Radiofrequency Ablation [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], 03 medical and health sciences, R5-920, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Internal medicine, Pancreatic cancer, Pàncrees - Càncer - Tractament, medicine, Humans, Chemotherapy, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], business.industry, Cancer, ADENOCARCINOMA, Other subheadings::/therapy [Other subheadings], medicine.disease, PHASE-III, Gemcitabine, Pancreatic Neoplasms, DEFINITION, GEMCITABINE, Human medicine, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3471da294f3f1dbd689adeaf8e6be22Test
https://repository.ubn.ru.nl/handle/2066/239066Test

المؤلفون: J. de Vos-Geelen, Eva Versteijne, G. van Tienhoven, O.R.C. Busch, Bert A. Bonsing, Mustafa Suker, C.J.A. Punt, Aeilko H. Zwinderman, K.B.C. Groothuis, Sebastiaan Festen, Gijs A. Patijn, I.H.J.T. de Hingh, C.H.J. van Eijck

مصطلحات موضوعية: Resectable Pancreatic Cancer, Cancer Research, medicine.medical_specialty, Preoperative chemoradiotherapy, business.industry, medicine.disease, Gemcitabine, Surgery, law.invention, 03 medical and health sciences, 0302 clinical medicine, Oncology, Randomized controlled trial, law, Borderline resectable, 030220 oncology & carcinogenesis, Pancreatic cancer, medicine, Clinical endpoint, Adenocarcinoma, 030211 gastroenterology & hepatology, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6704c80b22a2ec202b69e8031194d5Test
https://hdl.handle.net/1887/122931Test